How many email patterns does Savara Inc. use?

Savara Inc. uses 6 known email patterns.

What domain does Savara Inc. use for work emails?

Savara Inc. uses savarapharma.com for work email addresses.

Most Common Email Formats at Savara Inc.

Savara Inc.'s most common email format is First.Last@savarapharma.com (ex. John.Doe@savarapharma.com), used for 95% of savarapharma.com addresses. Savara Inc. uses 4 email patterns.

@savarapharma.com

4 patterns

Format	Example	Share of savarapharma.com
First.Last@savarapharma.comMost common	John.Doe@savarapharma.com	95%
Last@savarapharma.com	Doe@savarapharma.com	2%
FLast@savarapharma.com	JDoe@savarapharma.com	2%
F-Last@savarapharma.com	J-Doe@savarapharma.com	1%

Need a specific person's email?

Browse Savara Inc.'s employee directory (about 128 employees) and reveal verified emails free.

Frequently Asked Questions

What does Savara Inc. do?

Savara Inc. was founded in 2007 and operates in the Pharmaceutical Manufacturing industry, alongside similar companies like Frequency Therapeutics, Sarepta Therapeutics and Aridis Pharmaceuticals. You can visit savarapharma.com or contact Savara Inc.'s headquarters by phone at

+1-512-614-****

. Explore Savara Inc.'s company overview page for more information.

What is Savara Inc.'s email address format?

Savara Inc.'s email format typically follows the pattern of First.Last@savarapharma.com; this email format is used 95% of the time. Other contacts within LeadIQ's database had email formats such as Last@savarapharma.com and FLast@savarapharma.com. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Savara Inc. have currently?

Savara Inc. has approximately 128 employees as of October 2026. Key team members to contact include Vp Of Global Pharmacovigilance: N. R., Vice President Of Manufacturing: J. A. and Executive Vice President Global Commercial: S. W. For more team information and contact data, explore Savara Inc.'s employee directory with LeadIQ.

Savara Inc. Email Format

Pharmaceutical ManufacturingColorado, United States51-200 Employees

Savara Pharmaceuticals is a clinical-stage biopharmaceutical company focused on rare respiratory diseases. Its lead program MOLBREEVI is a recombinant human GM-CSF in Phase 3 development for autoimmune pulmonary alveolar proteinosis, delivered via an investigational eFlow Nebulizer System designed for inhalation of large molecules. The company is based in Colorado, United States, and its management team brings substantial experience in identifying unmet needs in pulmonary medicine and advancing candidates toward approval and commercialization.

In 2026, Savara announced that PANTHERx Rare Pharmacy was selected as the exclusive U.S. specialty pharmacy for MOLBREEVI.

Most common format

First.Last@savarapharma.com

Example: John.Doe@savarapharma.com

4 patterns. See all formats

Verify a Savara Inc. email address

Free with a LeadIQ account. No credit card.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Most Common Email Formats at Savara Inc.

@savarapharma.com

Need a specific person's email?

Frequently Asked Questions

What does Savara Inc. do?

What is Savara Inc.'s email address format?

How many employees does Savara Inc. have currently?

Savara Inc. Email Format

Ready to create more pipeline?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Everything for prospecting,
in one platform.